Medicaid expansion and provision of prescription contraception to Medicaid beneficiaries

Andrew Sumarsono, Matthew W. Segar, Luyu Xie, Folefac Atem, Sarah E. Messiah, Jenny KR Francis, Neil Keshvani

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Introduction: Medicaid expansion increased access to care, but longitudinal patterns of contraception use after the Medicaid expansion have not been described. Methods: We evaluated the effects of Medicaid expansion on the amount and type of contraceptive prescriptions using the Medicaid State Utilization Dataset. Results: Overall long-acting reversible contraception (LARC) use increased in both expansion and non-expansion states. In a difference-in-differences analysis, states that expanded Medicaid had no appreciable increase in per-capita prescription rates of LARC (p = 0.26) or short-acting hormonal contraception (p = 0.09) when compared to nonexpansion states. Discussion: The Medicaid expansion was not associated with a change in per-capita LARC or short-acting hormonal contraception use.

Original languageEnglish (US)
Pages (from-to)199-202
Number of pages4
Issue number3
StatePublished - Mar 2021


  • Access to care
  • Contraception
  • Health policy
  • Medicaid expansion
  • Prevention
  • Women's health

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology


Dive into the research topics of 'Medicaid expansion and provision of prescription contraception to Medicaid beneficiaries'. Together they form a unique fingerprint.

Cite this